The first new treatment for Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK.
Aducanumab targets the underlying cause of Alzheimer’s, the most common form of dementia, rather than its symptoms.
Charities have welcomed the news of a new therapy for the condition.
But scientists are divided over its potential impact because of uncertainty over the trial results.
Please subscribe HERE http://bit.ly/1rbfUog
#BBCNews
ROMA (ITALPRESS) – La Juventus vince la quindicesima Coppa Italia della sua storia. All’Olimpico di Roma la squadra bianconera gioca…
The Prime Minister of Slovakia has undergone hours of emergency surgery after being shot multiple times while leaving a government…
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
ROMA (ITALPRESS) – I confronti televisivi tra leader in vista delle Europee possono considerarsi legittimi “ove il relativo format sia…
Slovak Prime Minister Robert Fico is said to be in a "life-threatening condition" after he was shot and wounded. Several…